PSYD_0302: BIRMINGHAM

This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.A randomised, double-blind, placebo-controlled trial in participants with a recent-onset schizophrenia-spectrum disorder with continuing positive symptoms.Contributors and PIs: John F. W. DeakinNeuroscience and Psychiatry Unit, The University of Manchester, Manchester, UKInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UKKey Details & VariablesData TypeImage data/Feature dataAge Range19-34Number of Participants28Diagnostic CriteriaSCZNumber of Clinical Subjects18Number of Clinical Subjects (follow-up)10Number of Control SubjectsN/ANumber of Control Subjects (follow-up)N/ADemographic InformationAge, Sex, Ethnicity, Handedness, EducationClinical MeasuresPANSS, CDSS, EPS, MAH, COOCognitive MeasuresN/AClinical Functioning MeasuresGAFAntipsychotic Medication Information RecordedYesAntipsychotic Medication Name/ Antipsychotic TypeNameAntipsychotic Dose RecordedYesCPZ Equivalents RecordedN/AOther Medication Variables RecordedYesRecreational Drug/ Alcohol UseYesNote: the above table features key details and variables and is not an exhaustive list.